Terminated PHASE3 INTERVENTIONAL 4-arm NCT00897377

Treatment Strategy for Low-grade Gliomas

Sponsor: Sun Yat-sen University

Conditions Astrocytomas Oligoastrocytoma Oligodendrogliomas

Interventions Radiation therapy Temozolomide

Updated 5 times since 2017 Last updated: Aug 4, 2014 Started: Dec 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Difficulty in recruiting patients

Other terminated trials from Sun Yat-sen University

See all terminations from Sun Yat-sen University

Listed as NCT00897377, this PHASE3 trial focuses on Astrocytomas and Oligoastrocytoma and remains terminated or withdrawn. Sponsored by Sun Yat-sen University, it has been updated 5 times since 2007, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE3
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE3
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE3
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE3
Jan 2017 — Jun 2018 [monthly]

Terminated PHASE3

First recorded

Dec 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Sun Yat-sen University

Data source: Sun Yat-sen University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Guangzhou, China